The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE.
暂无分享,去创建一个
H. Akaza | O. Ogawa | M. Murai | S. Naito | H. Yamanaka | T. Kitamura | S. Kagawa | M. Namiki | T. Tsukamoto | Y. Hirao | S. Hinotsu | M. Usami
[1] P. Rubin,et al. Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10. , 2006, International journal of radiation oncology, biology, physics.
[2] M. Wirth,et al. Bicalutamide 150 mg in addition to standard care in patients with localized or locally advanced prostate cancer: results from the second analysis of the early prostate cancer program at median followup of 5.4 years. , 2004, The Journal of urology.
[3] J. Manola,et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. , 2004, JAMA.
[4] H. Akaza,et al. Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance. , 2004, Japanese journal of clinical oncology.
[5] M. Cooperberg,et al. National practice patterns and time trends in androgen ablation for localized prostate cancer. , 2003, Journal of the National Cancer Institute.
[6] Y. Homma,et al. A prospective and randomized study of primary hormonal therapy for patients with localized or locally advanced prostate cancer unsuitable for radical prostatectomy: results of the 5‐year follow‐up , 2003, BJU international.
[7] Jacques Bernier,et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial , 2002, The Lancet.
[8] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[9] H. Ohshima,et al. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy]. , 1990, Hinyokika kiyo. Acta urologica Japonica.
[10] C. Huggins,et al. STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND , 1941 .